Skip to content
10-Q

Quarterly Report

Enliven Therapeutics, Inc. ELVN

0001193125-25-179845

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 59.24M sh
Shares Diluted Q2 2025 · Jun 30, 2025 52.11M sh
Shares Diluted Q2 2025 · Jun 30, 2025 51.08M sh
Shares Diluted Q2 2025 · Jun 30, 2024 48.08M sh
Shares Diluted Q2 2025 · Jun 30, 2024 45.06M sh
Capex Q2 2025 · Jun 30, 2025 $159K
Capex Q2 2025 · Jun 30, 2024 $22K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$41.18M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$43.8M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $119.44M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $124.12M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $96.87M
Stockholders Equity Q2 2025 · Jun 30, 2025 $488.47M
Stockholders Equity Q2 2025 · Mar 31, 2025 $288.3M
Stockholders Equity Q2 2025 · Dec 31, 2024 $309.85M
Stockholders Equity Q2 2025 · Jun 30, 2024 $304.93M
Stockholders Equity Q2 2025 · Mar 31, 2024 $317.71M
Stockholders Equity Q2 2025 · Dec 31, 2023 $245.91M
Current Liabilities Q2 2025 · Jun 30, 2025 $15.21M
Current Liabilities Q2 2025 · Dec 31, 2024 $15.92M
Total Liabilities Q2 2025 · Jun 30, 2025 $15.42M
Total Liabilities Q2 2025 · Dec 31, 2024 $15.92M
Current Assets Q2 2025 · Jun 30, 2025 $495.62M
Current Assets Q2 2025 · Dec 31, 2024 $318.13M
Total Assets Q2 2025 · Jun 30, 2025 $503.89M
Total Assets Q2 2025 · Dec 31, 2024 $325.76M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.49
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.05
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.41
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.95
Eps Basic Q2 2025 · Jun 30, 2025 −$0.49
Eps Basic Q2 2025 · Jun 30, 2025 −$1.05
Eps Basic Q2 2025 · Jun 30, 2024 −$0.41
Eps Basic Q2 2025 · Jun 30, 2024 −$0.95
Sga Expense Q2 2025 · Jun 30, 2025 $7.09M
Sga Expense Q2 2025 · Jun 30, 2025 $13.89M
Sga Expense Q2 2025 · Jun 30, 2024 $5.78M
Sga Expense Q2 2025 · Jun 30, 2024 $11.79M
Rd Expense Q2 2025 · Jun 30, 2025 $21.49M
Rd Expense Q2 2025 · Jun 30, 2025 $46.39M
Rd Expense Q2 2025 · Jun 30, 2024 $18.83M
Rd Expense Q2 2025 · Jun 30, 2024 $38.8M
Net Income Q2 2025 · Jun 30, 2025 −$25.34M
Net Income Q2 2025 · Jun 30, 2025 −$53.88M
Net Income Q2 2025 · Mar 31, 2025 −$28.54M
Net Income Q2 2025 · Jun 30, 2024 −$19.95M
Net Income Q2 2025 · Jun 30, 2024 −$42.69M
Net Income Q2 2025 · Mar 31, 2024 −$22.74M
Operating Income Q2 2025 · Jun 30, 2025 −$28.58M
Operating Income Q2 2025 · Jun 30, 2025 −$60.28M
Operating Income Q2 2025 · Jun 30, 2024 −$24.6M
Operating Income Q2 2025 · Jun 30, 2024 −$50.59M